Abstract:Hepatitis C virus (HCV) only infects humans and chimpanzees, while GB virus B (GBV-B), another hepatotropic hepacivirus, infects small New World primates (tamarins and marmosets). In an effort to develop an immunocompetent small primate model for HCV infection to study HCV pathogenesis and vaccine approaches, we investigated the HCV life cycle step(s) that may be restricted in small primate hepatocytes. First, we found that replication-competent, genome-length chimeric HCV RNAs encoding GBV-B structural proteins in place of equivalent HCV sequences designed to allow entry into simian hepatocytes failed to induce viremia in tamarins following intrahepatic inoculation, nor did they lead to progeny virus in permissive, transfected human Huh7.5 hepatoma cells upon serial passage. This likely reflected the disruption of interactions between distantly related structural and nonstructural proteins that are essential for virion production, whereas such cross talk could be restored in similarly designed HCV intergenotypic recombinants via adaptive mutations in NS3 protease or helicase domains. Next, HCV entry into small primate hepatocytes was examined directly using HCV-pseudotyped retroviral particles (HCV-pp). HCV-pp efficiently infected tamarin hepatic cell lines and primary marmoset hepatocyte cultures through the use of the simian CD81 ortholog as a coreceptor, indicating that HCV entry is not restricted in small New World primate hepatocytes. Furthermore, we observed genomic replication and modest virus secretion following infection of primary marmoset hepatocyte cultures with a highly cell culture-adapted HCV strain. Thus, HCV can successfully complete its life cycle in primary simian hepatocytes, suggesting the possibility of adapting some HCV strains to small primate hosts. Importance: Hepatitis C virus (HCV) is an important human pathogen that infects over 150 million individuals worldwide and leads to chronic liver disease. The lack of a small animal model for this infection impedes the development of a preventive vaccine and pathogenesis studies. In seeking to establish a small primate model for HCV, we first attempted to generate recombinants between HCV and GB virus B (GBV-B), a hepacivirus that infects small New World primates (tamarins and marmosets). This approach revealed that the genetic distance between these hepaciviruses likely prevented virus morphogenesis. We next showed that HCV pseudoparticles were able to infect tamarin or marmoset hepatocytes efficiently, demonstrating that there was no restriction in HCV entry into these simian cells. Furthermore, we found that a highly cell culture-adapted HCV strain was able to achieve a complete viral cycle in primary marmoset hepatocyte cultures, providing a promising basis for further HCV adaptation to small primate hosts.

Serological and histological changes of rhesus monkey infected with HGV RNA transcripts

Significance of serological markers and virological marker for hepatitis E in rhesus monkey model

Evaluation of antibody-based and nucleic acid-based assays for diagnosis of hepatitis E virus infection in a rhesus monkey model.

Swine hepatitis E virus in rural southern China: genetic characterization and experimental infection in rhesus monkeys ( Macaca mulatta )

A high frequency of GBV-C/HGV coinfection in hepatitis C patients in Germany.

Transcriptome analysis in rhesus macaques infected with hepatitis E virus genotype 1/3 infections and genotype 1 re-infection

[Detection of Hepatitis E Virus on a Blood Donor and Its Infectivity to Rhesus Monkey].

Infectivity titration of a prototype strain of hepatitis E virus in cynomolgus monkeys

Study on clinical features of hepatitis G virus infection and HGV invasion to peripheral blood mononuclear cells

Determinants Involved in Hepatitis C Virus and GB Virus B Primate Host Restriction

An Animal Model of Human Cytomegalovirus Infection

Long-term hepatitis B virus infection of rhesus macaques requires suppression of host immunity

Title Acute infection of chinese macaques by a CCR 5-tropic SHIVcarrying a primary HIV-1 subtype B ' envelope

Acute and long term toxicity effects of herpes simplex virus Ⅰ thymidine kinase gene and ganciclovir system in non-human primates

Infection of Rhesus Macaques by SIVmac239 Virus Inoculated Rectally

Titration of a SHIV1157ipd3N4 Stock by Intravenous Inoculation of Chinese-Origin Rhesus Macaques

The Propagation and Evaluation of SHIVSF162P3Adapative Virus Stock in Chinese-Origin Rhesus Macaques

Infectivity and Pathogenicity of Different Hepatitis E Virus Genotypes/subtypes in Rabbit Model

Hiv-2 in Rhesus-Monkeys - Serological, Virological and Clinical-Results

Humoral and cellular immunogenecity of nucleic acid vaccine of hepatitis B core antigen in rhesus monkeys

HTLV type 1 infection in squirrel monkeys (Saimiri sciureus): a promising animal model for HTLV type 1 human infection